On Tuesday, Ventyx Biosciences Inc (NASDAQ: VTYX) opened lower -3.63% from the last session, before settling in for the closing price of $9.08. Price fluctuations for VTYX have ranged from $0.78 to $10.55 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -87.13% over the last five years. Company’s average yearly earnings per share was noted 26.52% at the time writing. With a float of $63.98 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ventyx Biosciences Inc is 10.34%, while institutional ownership is 62.17%. The most recent insider transaction that took place on Dec 18 ’25, was worth 365,461. In this transaction CEO AND PRESIDENT of this company sold 47,345 shares at a rate of $7.72, taking the stock ownership to the 2,372,863 shares. Before that another transaction happened on Dec 18 ’25, when Company’s CHIEF SCIENTIFIC OFFICER sold 12,675 for $7.72, making the entire transaction worth $97,840. This insider now owns 489,481 shares in total.
Ventyx Biosciences Inc (VTYX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.41 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.89% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Check out the current performance indicators for Ventyx Biosciences Inc (VTYX). In the past quarter, the stock posted a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Analysing the last 5-days average volume posted by the [Ventyx Biosciences Inc, VTYX], we can find that recorded value of 0.68 million was lower than the volume posted last year of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 74.23%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 78.32%, which indicates a significant increase from 59.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.51 in the past 14 days, which was higher than the 0.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.41, while its 200-day Moving Average is $3.77. Now, the first resistance to watch is $9.03. This is followed by the second major resistance level at $9.30. The third major resistance level sits at $9.51. If the price goes on to break the first support level at $8.54, it is likely to go to the next support level at $8.33. Should the price break the second support level, the third support level stands at $8.06.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are currently 71,359K shares outstanding in the company with a market cap of 624.39 million. Presently, the company’s annual sales total 0 K according to its annual income of -135,120 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -22,830 K.
